Infection prevention and antimicrobial stewardship: Important in all settings

Healthcare Infection

Volumn 20, Issue 1, 2015, Pages 1-3

  Friedman, N Deborah ^a,b  

^a UNIVERSITY HOSPITAL GEELONG   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; ARTICLE; DISINFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; PRISON; RESIDENTIAL CARE; TATTOOING;

EID: 84923923118     PISSN: 18355617     EISSN: 18355625     Source Type: Journal    
DOI: 10.1071/HI15001     Document Type: Editorial

References (26)

1. Friedman ND, Sexton DJ. General Principles of Infection Control. In: UpToDate. Rose, BD (ed), UpToDate. Waltham, MA; 2007.
2. Sia HJ, Levy M. What have you heard about tattooing in prison? The clandestine role of hearing aids in the risk of bloodborne virus transmission. Healthc Infect 2015; 20: 36-37. doi:10.1071/ HI14032
3. Australian Institute of Health and Welfare. The Health of Australian Prisoners 2012. Canberra: AIHW; 2013. Available from: http://www. aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129543945 [Verified January 2015]
4. Elegino-Steffens DU, Layman C, Bacomo F, Hsue G.Acase of severe septicemia following traditional Samoan tattooing. Hawaii J Med Public Health 2013; 72: 5-9.
5. Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect 2004; 132: 409-15. doi:10.1017/S0950268803001882
6. Hellard ME, Aitken CK, Hocking JS. Tattooing in prisons- not such a pretty picture. Am J Infect Control 2007; 35: 477-80. doi:10.1016/ j.ajic.2006.08.002
7. Rodas A, Bode A, Dolan, K. Supply, demand and harm reduction strategies in Australian prisons an update. Sydney: Australian National Council on Drugs; 2011.
8. Stuart RL, Orr E, Kotsanas D, Gillespie EE. A nurse-led antimicrobial stewardship intervention in two residential aged care facilities. Healthc Infect 2015; 20: 4-6. doi:10.1071/HI14016
9. March A, Aschbacher R, Dhanji H, Livermore DM, Böttcher A, Sleghel F, Maggi S, Noale M, Larcher C, Woodford N. Colonization of residents and staff of a long-term-care facility and adjacent acutecare hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect 2010; 16: 934-44. doi:10.1111/j.1469-0691.2009.03024.x
10. Pop-Vicas AE, Mitchell SL, Kandel R, Schreiber R, D 'Agata EM. Multidrug-resistant Gram-negative bacteria in a long-term care facility: prevalence and risk factors. J AmGeriatr Soc 2008; 56: 1276-80. doi:10.1111/j.1532-5415.2008.01787.x
11. Loeb MB, Craven S, McGeer AJ, Simor AE, Bradley SF, Low DE, Armstrong-Evans M, Moss LA, Walter SD. Risk factors for resistance to antimicrobial agents among nursing home residents. AmJ Epidemiol 2003; 157: 40-7. doi:10.1093/aje/kwf173
12. Tinelli M, Cataldo M, Mantengoli E, Cadeddu C, Cunietti E, Luzzaro F, Rossolini GM, Tacconelli E. Epidemiology and genetic characteristics of extended-spectrum beta-lactamase-producing Gramnegative bacteria causing urinary tract infections in long-term care facilities. J Antimicrob Chemother 2012; 67: 2982-7. doi:10.1093/jac/ dks300
13. Lim CJ, McLellan SC, Cheng AC, Culton JM, Parikh SN, Peleg AY, Kong DC. Surveillance of infection burden in residential aged care facilities. Med J Aust 2012; 196: 327-31. doi:10.5694/mja12.10085
14. Smith M, Atkins S, Worth L, Richards M, Bennett N. Infections and antimicrobial use in Australian residential aged care facilities: a comparison between local and international prevalence and practices. Aust Health Rev 2013; 37: 529-34. doi:10.1071/AH12007
15. Stuart RL, Wilson J, Bellaard-Smith E, Brown R, Wright L, Vandergraaf S, Gillespie EE. Antibiotic use and misuse in residential aged care facilities. Intern Med J 2012; 42: 1145-9. doi:10.1111/ j.1445-5994.2012.02796.x
16. Smith PW, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, Mody L, Nicolle L, Stevenson K; SHEA; APIC. SHEA/APIC guideline: infection prevention and control in the long-term care facility. Infect Control Hosp Epidemiol 2008; 29: 785-814. doi:10.1086/592416
17. Lim CJ, Kong DCM, Stuart RL. Reducing inappropriate antibiotic prescribing in the residential care setting: current perspectives. Clin Interv Aging 2014; 9: 165-77.
18. Friedman ND. Antimicrobial Stewardship: The Need to Cover All Bases. Antibiotics 2013. Antibiotics 2013; 2: 400-18. doi:10.3390/ antibiotics2030400
19. PasayDK,ChowSJS, Bresee LC,GuirguisM,Slobodan J. Assessment of current antimicrobial stewardship policies and resources: a focus group project. Healthc Infect 2015; 20: 7-15. doi:10.1071/HI14025
20. Harbarth S, Albrich W, Brun-Buisson C. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis 2002; 8: 1460-7. doi:10.3201/eid0812.010533
21. BratzlerDW,Patchen Dellinger E, OlsenKM,PerlTM,Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA; American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America. Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery. AmJ Health Syst Pharm 2013; 70: 195-283. doi:10.2146/ajhp120568
22. Dancer SJ. Hospital cleaning in the 21st century. Eur J Clin Microbiol Infect Dis 2011; 30: 1473-81. doi:10.1007/s10096-011-1250-x
23. Gibbs SG, Sayles H, Chaika O, Hewlett A, Colbert EM, Smith PW. Evaluation of the relationship between ATP bioluminescence assay and the presence of organisms associated with healthcare-associated infections. Healthc Infect 2014; 19: 101-7. doi:10.1071/HI14010
24. Sciortino CV, Giles RA. Validation and comparison of three adenosine triphosphate luminometers for monitoring hospital surface sanitization: a Rosetta Stone for adenosine triphosphate testing. Am J Infect Control 2012; 40: e233-9. doi:10.1016/j. ajic.2012.04.318
25. ColbertEM,Gibbs SG, SchmidKK,High R,LoweJJ, Chaika O, Smith PW. Evaluation of adenosine triphosphate (ATP) bioluminescence assay to confirm surface disinfection of biological indicators with vaporised hydrogen peroxide (VHP). Healthc Infect 2015; 20: 16-22. doi:10.1071/HI14022
26. Hall L, Halton K, Macbeth D, Gardner A, Mitchell B. Roles, responsibilities and scope of practice: Describing the 'state of play' for infection control professionals in Australia and New Zealand. Healthc Infect 2015; 20: doi:10.1071/HI14037